This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mesnil, M. Articles by Yamasaki, H. Search for Related Content PubMed PubMed Citation Articles by Mesnil, M. Articles by Yamasaki, H.

A Tumor Suppressor Gene, Cx26, Also Mediates the Bystander Effect in HeLa Cells¹

Unit of Multistage Carcinogenesis, IARC, 150 cours A. Thomas, 69372 Lyon Cedex 08, France

The connexin 26 (CX26) gene suppresses the growth of HeLa cells in vitro and in vivo. We explored the possibility that the Cx26 gene not only suppresses growth but can also mediate the bystander effect that is observed in some gene therapy. In gene therapy mediated by the herpes simplex virus thymidine kinase, the toxicity of ganciclovir affects not only the cells transduced with the gene but also affects neighboring tumor cells; it has been suggested that gap junctional intercellular communication (GJIC) may play a role in such a bystander effect. HeLa cells expressing the Cx26 gene (Cx26⁺) or not expressing the Cx26 gene were transfected with the herpes simplex virus thymidine kinase (tk⁺) gene, producing Cx26^--tk^-, Cx26^--tk⁺, Cx26⁺-tk^-, and Cx26⁺-tk⁺ cells. By making different kinds of cocultures of these cells, we observed a clear bystander killing effect, assessed by the neutral red toxicity test, in the coculture of Cx26⁺-tk^-/Cx26⁺-tk⁺ cells. The bystander effect was markedly prevented by a long-term inhibitor of GJIC, 18--glycyrrhetinic acid, demonstrating that a major part of the bystander effect seen occurred through Cx-mediated GJIC. These data suggest the possibility of using of Cxs as both tumor suppressor genes and as diffusers of ganciclovir toxicity in therapeutic approaches.

¹ Part of this work was financially supported by European Commission Environment Program Grant CT940421 (to H. Y.) and by Grants 96-27 from the Association for International Cancer Research (St. Andrews, Scotland) and from the Association pour la Recherche sur le Cancer (to M. M.)

² To whom requests for reprints should be addressed. Phone: 33(0)472-73-85-90; Fax: 33(0)472-73-84-42; E-mail: mesnil@iarc.fr.

Received 1/13/97. Accepted 5/14/97.

This article has been cited by other articles:

				D. S. Sanches, C. G. Pires, H. Fukumasu, B. Cogliati, P. Matsuzaki, L. M. Chaible, L. N. Torres, C. R. A. Ferrigno, and M. L. Z. Dagli Expression of Connexins in Normal and Neoplastic Canine Bone Tissue Veterinary Pathology, September 1, 2009; 46(5): 846 - 859. [Abstract] [Full Text] [PDF]

				M. Trepel, C. A. Stoneham, H. Eleftherohorinou, N. D. Mazarakis, R. Pasqualini, W. Arap, and A. Hajitou A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer Mol. Cancer Ther., August 1, 2009; 8(8): 2383 - 2391. [Abstract] [Full Text] [PDF]

				B. G. Gentry, P. D. Boucher, and D. S. Shewach Hydroxyurea Induces Bystander Cytotoxicity in Cocultures of Herpes Simplex Virus Thymidine Kinase-Expressing and Nonexpressing HeLa Cells Incubated with Ganciclovir. Cancer Res., April 1, 2006; 66(7): 3845 - 3851. [Abstract] [Full Text] [PDF]

				S. Fukushima, A. Kinoshita, R. Puatanachokchai, M. Kushida, H. Wanibuchi, and K. Morimura Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens Carcinogenesis, November 1, 2005; 26(11): 1835 - 1845. [Abstract] [Full Text] [PDF]

				A. Muramatsu, M. Iwai, T. Morikawa, S. Tanaka, T. Mori, Y. Harada, and T. Okanoue Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells Carcinogenesis, February 1, 2002; 23(2): 351 - 358. [Abstract] [Full Text] [PDF]

				Y. Zou, H. Peng, B. Zhou, Y. Wen, S.-C. Wang, E.-M. Tsai, and M.-C. Hung Systemic Tumor Suppression by the Proapoptotic Gene bik Cancer Res., January 1, 2002; 62(1): 8 - 12. [Abstract] [Full Text] [PDF]

				M. Mesnil and H. Yamasaki Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1 Cancer Res., August 1, 2000; 60(15): 3989 - 3999. [Abstract] [Full Text]

				L. Z. Rubsam, P. D. Boucher, P. J. Murphy, M. KuKuruga, and D. S. Shewach Cytotoxicity and Accumulation of Ganciclovir Triphosphate in Bystander Cells Cocultured with Herpes Simplex Virus Type 1 Thymidine Kinase-expressing Human Glioblastoma Cells Cancer Res., February 1, 1999; 59(3): 669 - 675. [Abstract] [Full Text] [PDF]

				Z. J. Tu, R. Kollander, and D. T. Kiang Differential Up-Regulation of Gap Junction Connexin 26 Gene in Mammary and Uterine Tissues: The Role of Sp Transcription Factors Mol. Endocrinol., December 1, 1998; 12(12): 1931 - 1938. [Abstract] [Full Text]